Curlim
PrivateLast Round
Seed
Jan 9, 2025
Total Funding Raised
$1.54M
Company Overview
Curlim is a biotechnology company developing CLM001, a nanomedicine designed to treat peripheral neuropathies such as Charcot-Marie-Tooth disease type 1A (CMT1A).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
nanomedicineCharcot-Marie-Tooth diseaseCMT1Aperipheral neuropathydrug deliveryorphan drugrare disease therapycurcumin formulationpharmaceutical licensingpre-clinical biotechdrug developmentnano-formulationuniversity spin-offcyclodextrinscellulose nanocrystals
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curlim Comps
Public and private peers based on sector, stage, and business model.
Curlim Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 9, 2025 |
Curlim Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nouvelle-Aquitaine Co-investissement | Seed |
| Aquiti Gestion | Seed |
Curlim Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curlim's valuation, stock price, and market status.
